Beam Therapeutics, Inc. (BEAM)
30.94
-0.28
(-0.88%)
USD |
NASDAQ |
Jan 20, 16:00
30.97
+0.02
(+0.08%)
After-Hours: 20:00
Beam Therapeutics Market Cap: 3.140B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.484B |
| Twist Bioscience Corp. | 2.553B |
| ANI Pharmaceuticals, Inc. | 1.927B |
| Pacific Biosciences of California, Inc. | 710.99M |
| Regeneron Pharmaceuticals, Inc. | 77.11B |
Market Cap Related Metrics
| PS Ratio | 52.13 |
| PEG Ratio | -0.0459 |
| Price to Book Value | 3.251 |
| Price | 30.94 |
| Earnings Yield | -14.33% |
| PEGY Ratio | -0.0459 |